Tag:
Enanta
Latest Headlines
Latest Headlines
Novartis snags preclinical hep C drug in $440M Enanta pact
Novartis ( $NVS ) has signed a $440 million pact to license a preclinical NS5A drug from Enanta Pharmaceuticals.
Enanta lands $43M NIAID development contract
Watertown, MA-based Enanta Pharmaceuticals reports that it has won a 5-year development contract with the National Institute of Allergy and Infectious Diseases (NIAID) which will provide up to $42.7
